A new advanced test has been developed by UroSens ltd, a recenlty founded company specialising in cancer research technology. The company has recently received £2 million to commercialise the Mcm5-ELISA…
Read More
Start with an initial specialist consultation
We’ll assess, diagnose, and put together a personalised treatment plan so you know exactly where you stand. Online or in-clinic.


